← Back
MDxHealth
MDXH · listed on Nasdaq · worth $18.32 million
$0.1920
−2.54% on Oct 28
One insider buy in the last year, $1000K in all. None in the last two weeks.
Different buyers at onceDirector MVM Partners bought, and 2 big investors reported new or larger stakes, within 3 days · Aug 17
Green dot = an insider boughtA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
42.5M shares
45% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought MDxHealth stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
MVM Partners
Bought $1000K on Aug 13 — 2,202,643 shares at $0.4540, held through a trust or family, 32% of what they now own.
First purchase we have on file
Planned sales
Form 144 notices filed for MDxHealth in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
10% holder Bleichroeder LP filed to sell 1,500,000 shares on 17 Sep; no sale reported yetNotice on SEC.gov
Big investors
People and funds that reported owning 5% or more of MDxHealth, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateBleichroeder LP32.0%Oct 15Reported stake, oldest first: 33.2% (Aug 14) → 32.0% (Oct 15)
Filed by someone who owns 5% or more and does not plan to influence the company. · updateLytton Laurence W19.5%Aug 17Reported stake, oldest first: 9.6% (Aug 13) → 19.5% (Aug 17)Crossed 10%
Filed by someone who owns 5% or more and may try to influence how the company is run.Bleichroeder LP33.2%Aug 14
Filed by someone who owns 5% or more and does not plan to influence the company. · updateLytton Laurence W9.6%Aug 13
Filed by someone who owns 5% or more and does not plan to influence the company. · updateAWM Investment Company0.0%Jul 8
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for MDxHealth.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Aug 17BoughtMVM PartnersAug 17 · Traded Aug 13 · Director+32%via a trust or family2,202,643 @ $0.4540$1000K
Analysts, earnings and news
Analysts' price target
$1.80 average
5 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
1 of 4 quarters above
Q2 '26−$0.18 a share+$0.01
Q1 '26−$0.17 a share−$0.02
Q4 '25−$0.17 a share−$0.04
Q3 '25−$0.16 a share−$0.05